![](/img/cover-not-exists.png)
B01*Negative influence of Melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of metastatic melanoma (MM) patients (pts) harboring BRAF mutation and treated with BRAF inhibitors (BRAFi)
Guida, M., Strippoli, S., Albano, A., Ferretta, A., Bartolomeo, N., Greco, C., Guida, S., Natalicchio, I., Tommasi, S., Azzariti, A., Guida, G.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv337.01
Date:
October, 2015
File:
PDF, 35 KB
english, 2015